Phencyclidine reduces postischemic neuronal necrosis in rat hippocampus without changing blood flow.
In this report the effects of phencyclidine (PCP) on physiologic variables, local cerebral blood flow (LCBF), and on hippocampal cell damage were measured in a rat model of forebrain ischemia (2-vessel occlusion and hypotension). Ischemia was induced for 10 min. LCBF was determined after 2 min of recirculation, using the [14C]iodoantipyrine technique. Hippocampal cell loss was quantified histologically 7 days postischemia as the percentage of acidic stainable neurons. Intravenous application of PCP (2 mg/kg) at 15 min prior to ischemia left postischemic LCBF unchanged, but neuronal damage was significantly reduced in hippocampal CA1 sector from 46 to 15.7%. PCP is concluded to reduce ischemic damage of neurons mainly via a direct effect on brain tissue.
Sauer
D
D
Institut für Pharmakologie und Toxikologie, Philipps-Universität, Marburg, F.R.G.
Nuglisch
J
J
Rossberg
C
C
Mennel
H D
HD
Beck
T
T
Bielenberg
G W
GW
Krieglstein
J
J
D000818:Animals; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D006624:Hippocampus / Q000473:pathology* / Q000503:physiopathology; D002546:Ischemic Attack, Transient / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D008297:Male; D009336:Necrosis; D010622:Phencyclidine / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains
D010622:Phencyclidine